Patents Assigned to Biotech Institute LLC
  • Patent number: 10582676
    Abstract: The invention provides compositions and methods for the breeding, production, processing and use of specialty cannabis.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: March 10, 2020
    Assignee: Biotech Institute, LLC
    Inventors: Mark Anthony Lewis, Michael D Backes, Matthew W Giese
  • Patent number: 10502750
    Abstract: The present invention teaches methods useful for accurately and precisely analyzing cannabis plants, plant parts, and extract samples. In particular, the present invention teaches methods of extracting, and quantifying cannabinoid and terpene constituents.
    Type: Grant
    Filed: December 23, 2015
    Date of Patent: December 10, 2019
    Assignee: Biotech Institute, LLC
    Inventors: Matthew W. Giese, Mark Anthony Lewis, Laura Giese
  • Patent number: 10441617
    Abstract: The invention provides compositions and methods for the breeding, production, processing and use of medical cannabis.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: October 15, 2019
    Assignee: Biotech Institute, LLC
    Inventors: Mark Anthony Lewis, Michael Dane Backes
  • Patent number: 9642317
    Abstract: The invention provides compositions and methods for the breeding, production, processing and use of specialty cannabis.
    Type: Grant
    Filed: May 11, 2016
    Date of Patent: May 9, 2017
    Assignee: Biotech Institute, LLC.
    Inventors: Mark Anthony Lewis, Michael D Backes, Matthew W Giese
  • Patent number: 9370164
    Abstract: The invention provides compositions and methods for the breeding, production, processing and use of specialty Cannabis.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: June 21, 2016
    Assignee: Biotech Institute, LLC
    Inventors: Mark Anthony Lewis, Michael D Backes, Matthew W Giese
  • Patent number: 9095554
    Abstract: The invention provides compositions and methods for the breeding, production, processing and use of specialty cannabis.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: August 4, 2015
    Assignee: Biotech Institute LLC
    Inventors: Mark Anthony Lewis, Michael D Backes, Matthew Giese
  • Publication number: 20140298511
    Abstract: The invention provides compositions and methods for the breeding, production, processing and use of medical cannabis.
    Type: Application
    Filed: March 17, 2014
    Publication date: October 2, 2014
    Applicant: BIOTECH INSTITUTE, LLC
    Inventors: Mark Anthony Lewis, Michael Dane Backes
  • Publication number: 20140287068
    Abstract: The invention provides compositions and methods for the breeding, production, processing and use of specialty cannabis.
    Type: Application
    Filed: March 17, 2014
    Publication date: September 25, 2014
    Applicant: Biotech Institute LLC
    Inventors: Mark Anthony LEWIS, Michael D. Backes, Matthew Giese
  • Patent number: PP31535
    Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘LEMON CRUSH OG’. The main terpenes found in ‘LEMON CRUSH OG’ are limoene, beta-caryophyllene, alpha-humulene, linalool, trans-ocimene, beta-pinene, fenchol, alpha-terpineol, alpha-pinene and myrcene. The estimated concentration of the total THCmax, CBDmax, and CBGmax is about 18.77-23.19%, about 0%, and about 0.98-1.78%, respectively, at the time of assaying metabolites from flower samples of ‘LEMON CRUSH OG’. Harvest interval, i.e. at 56-70 days under short day conditions.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: March 10, 2020
    Assignee: Biotech Institute LLC
    Inventors: Mark A. Lewis, Steven Haba
  • Patent number: PP31707
    Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘GRAPE LOLIPOP’. Disclosed herein are main terpenes of ‘GRAPE LOLIPOP’, which are myrcene, limonene, beta-caryophyllene, alpha-pinene, alpha-humulene, beta-pinene, and linalool. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 3.09-7.59%, about 9.97-16.68% and about 0.21-0.70% respectively, at the time of assaying metabolites from flower samples of ‘GRAPE LOLIPOP’.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: April 28, 2020
    Assignee: Biotech Institute, LLC
    Inventors: Mark Anthony Lewis, Steven Robert Haba
  • Patent number: PP31724
    Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘PRIMO CHERRY’. Disclosed herein are main terpenes of ‘PRIMO CHERRY’, which are myrcene, alpha-pinene, hexyl butyrate, beta-pinene, limonene, and linalool. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 12.38-15.24%, about 5.40-7.13%, and about 0.22-0.33%, respectively, at the time of assaying metabolites from flower samples of ‘PRIMO CHERRY’.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: May 5, 2020
    Assignee: Biotech Institute, LLC
    Inventors: Mark Anthony Lewis, Steven Robert Haba
  • Patent number: PP31752
    Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘CAKE BATTER COOKIES’. Disclosed herein are main terpenes of ‘CAKE BATTER COOKIES’, which are limonene, beta-caryophyllene, beta-pinene, linalool, alpha-humulene, alpha-pinene, fenchol, myrcene, alpha-bisabolol, and alpha-terpineol. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 6.5-14.21%, about 5.36-9.82%, and about 0.11-0.42%, respectively, at the time of assaying metabolites from flower samples of ‘CAKE BATTER COOKIES’.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: May 12, 2020
    Assignee: Biotech Institute, LLC
    Inventors: Mark A. Lewis, Steven Haba
  • Patent number: PP31874
    Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘HOLY CRUNCH’. Disclosed herein are main terpenes of ‘HOLY CRUNCH’, which are beta-caryophyllene, limonene, myrcene, linalool, alpha-humulene, trans-ocimene, alpha-bisabolol, and alpha-pinene. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 6.56-16.74%, about 6.49-15.28%, and about 0.25-1.87%, respectively, at the time of assaying metabolites from flower samples of ‘HOLY CRUNCH’.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: June 16, 2020
    Assignee: Biotech Institute, LLC
    Inventors: Mark Anthony Lewis, Steven Robert Haba
  • Patent number: PP31917
    Abstract: The present invention provides a new and distinct cannabis cultivar designated as ‘RASPBERRY PUNCH’. Disclosed herein are main terpenes of ‘RASPBERRY PUNCH,’ which are limonene, myrcene, beta-caryophyllene, linalool, alpha-humulene, alpha-bisabolol, and beta-pinene. Also, the present invention provides the estimated concentration of the THCmax, CBDmax, and CBGmax, about 4.94-8.64%, about 12.04-17.74%, and about 0.59-1.01%, respectively, at the time of assaying metabolites from flower samples of ‘RASPBERRY PUNCH’.
    Type: Grant
    Filed: November 5, 2018
    Date of Patent: June 30, 2020
    Assignee: Biotech Institute, LLC
    Inventors: Mark Anthony Lewis, Steven Robert Haba
  • Patent number: PP31918
    Abstract: The present invention provides a new and distinct Cannabis cultivar designated as ‘RAINBOW GUMMEEZ.’ Disclosed herein are main terpenes of ‘RAINBOW GUMMEEZ’ which are terpinolene, myreene, alpha-pinene, alpha-terpineol, trans-ocimene, beta-pinene, and beta caryophyllene. Also, the present invention provides the estimated concentration of the THCmax, CBDmax and CBGmax, about 4.37-7.87%, about 5.18-9.48%, and about 0.14-0.60%, respectively, at the time of assaying metabolites from flower samples of ‘RAINBOW GUMMEEZ.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: June 30, 2020
    Assignee: Biotech Institute, LLC
    Inventors: Mark Anthony Lewis, Steven Robert Haba